Department of Neurology, Cleveland Clinic, Cleveland, OH, USA.
Headache. 2013 Oct;53(9):1482-7. doi: 10.1111/head.12202. Epub 2013 Sep 3.
To report fulminant cases of reversible cerebral vasoconstriction syndrome (RCVS) in the setting of serotonin syndrome.
RCVS is characterized by acute onset of severe headaches, with or without neurologic deficit, with evidence of reversible cerebral vasoconstriction. It is often benign, and prognosis is generally considered favorable. In the largest prospective study on RCVS, only 4% of patients were disabled from strokes and there were no fatalities.
We report a case series.
We report 2 women with history of depression on selective serotonin re-uptake inhibitors who presented with thunderclap headache and dizziness, respectively. Through the course of hospitalization, both patients developed rigidity, diaphoresis, fever, tachycardia with labile blood pressures and clonus on examination. Since there was a recent addition/increase in a known serotonergic agent, they met criteria for serotonin syndrome. Cerebrovascular imaging in both patients revealed severe multi-focal vessel narrowing. The first patient developed large bi-hemispheric ischemic infarcts and increased intra-cranial pressure that was refractory to management, and she eventually expired. The second patient developed bilateral parieto-occipital strokes and decerebrate posturing. Her course slowly stabilized, and she was eventually discharged with residual left-sided hemiparesis. Repeat cerebrovascular imaging 1 month later showed normal vessels. In both patients, intra-arterial nicardipine infusion improved angiographic appearance of stenoses, consistent with RCVS.
Both cases satisfied the Sternbach criteria for serotonin syndrome. Fatality in case 1 prevents demonstration of reversal of cerebral vasoconstriction, but improvement of arterial diameters with intra-arterial calcium channel blockers in both cases suggests that both had RCVS. Serotonergic agents are known triggers of RCVS, but the concurrent presence of serotonin syndrome likely precipitated the malignant course in our patients. Severe clinical and angiographic manifestations should be considered as part of the spectrum of RCVS.
报告血清素综合征背景下可逆性脑动脉收缩综合征(RCVS)的暴发性病例。
RCVS 的特征是突发严重头痛,伴有或不伴有神经功能缺损,并有可逆性脑血管收缩的证据。它通常是良性的,预后一般被认为是良好的。在 RCVS 的最大前瞻性研究中,只有 4%的患者因中风而残疾,没有死亡。
我们报告了一系列病例。
我们报告了 2 例有抑郁病史的女性,分别因突发头痛和头晕就诊。在住院过程中,两名患者均出现僵硬、出汗、发热、心动过速伴血压波动和阵挛。由于最近增加了一种已知的血清素能药物,她们符合血清素综合征的标准。两名患者的脑血管成像均显示严重的多灶性血管狭窄。第 1 例患者发生大面积双侧半球性缺血性梗死和颅内压增高,且对治疗无反应,最终死亡。第 2 例患者发生双侧顶枕叶中风和去大脑强直。她的病情逐渐稳定,最终出院时仍遗留左侧偏瘫。1 个月后重复脑血管成像显示血管正常。在这两例患者中,动脉内尼卡地平输注改善了狭窄的血管造影表现,与 RCVS 一致。
这两例均符合血清素综合征的 Sternbach 标准。第 1 例患者的死亡阻止了对脑血管收缩逆转的证明,但在两例患者中,动脉内钙通道阻滞剂改善了动脉直径,提示均有 RCVS。血清素能药物是 RCVS 的已知触发因素,但血清素综合征的同时存在可能使我们的患者病情恶化。严重的临床和血管造影表现应被视为 RCVS 谱的一部分。